PatientsVille.com Logo


Osteoporosis Medical Research Studies

Up-to-date List of Osteoporosis Medical Research Studies

What Research is Being Done?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. Following list includes both interventional and observational studies.

Latest Osteoporosis Medical Research Studies

Rank Status Study
1 Unknown  Osteoporosis Among Men Treated With Androgen Deprivation for Prostate Cancer
Conditions: Prostate Cancer;   Androgen Deprivation Therapy;   Osteoporosis
Intervention: Procedure: blood sampling, DXA-scan, bone scintigraphy
Outcome Measure: Osteoporosis, either T-score < -2,5 or Osteoporosis fracture
2 Recruiting Evaluation of an Osteoporosis Prevention Strategy in Women With Osteoporotic Fracture of the Upper Limb
Condition: Osteoporosis With Current Fragility Fracture
Intervention: Behavioral: Osteoporosis prevention program
Outcome Measures: Proportion of women in the 2 groups who initiated a management of Osteoporosis at 6 months (BMD or Osteoporosis treatment prescription).;   Proportion of women in the two groups who performed BMD at 6 months;   Proportion of women in the two groups with an increased perception of fracture risk.;   Proportion of women in the two groups who changed their behaviour in order to prevent future fractures: regular practice of physical activity, dairy products consumption and calcium and vitamin D supplementation.;   Proportion of women who improved their knowledge about Osteoporosis
3 Unknown  Osteoporosis Coordinator for Low Volume Community Hospitals
Conditions: Osteoporosis;   Fragility Fractures
Interventions: Behavioral: centralized Osteoporosis coordinator;   Behavioral: fall prevention
Outcome Measures: proportion of patients from the intervention group as compared to the control group that had "appropriate management" based on a composite of undergoing a BMD test and starting therapy within 6 months of fracture.;   Osteoporosis knowledge, perceived susceptibility, self-efficacy, preventive behaviors;   participants' experience and perceptions of future fracture risk; their understanding of the educational materials and acceptance of recommended treatment plans.
4 Recruiting Forteo Trial on Idiopathic Osteoporosis in Premenopausal Women
Condition: Adult Idiopathic Generalized Osteoporosis
Interventions: Drug: Teriparatide;   Drug: Saline Placebo
Outcome Measure: Change in lumbar spine bone mineral density (LS-BMD)
5 Recruiting Study on the microRNA Expression Level in Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Intervention: Other: Osteoporosis
Outcome Measure: microRNA expression lever in the Peripheral Blood
6 Recruiting Age Dependend Diagnostic Thresholds for Osteoporosis Bindex Ultrasonometer
Condition: Osteoporosis
Outcome Measure: Thresholds for Bindex in Osteoporosis Diagnostics
7 Unknown  Multi-joint Coordination Underlies Upright Balance Control in Elderly With Osteoporosis
Condition: Osteoporosis
Outcome Measure:
8 Recruiting Osteoporosis in RETT Syndrome
Condition: RETT Syndrome With Proven MECP2 Mutation
Intervention: Other: biological markers and evaluation of the mineral density at the lumber spine using DEXA
Outcome Measures: Osteoporosis in RETT patients;   Biological Mechanisms of Osteoporosis
9 Unknown  A Interventional Study of Geriatric Frailty, Osteoporosis, and Depression
Conditions: Frailty;   Osteoporosis;   Depression
Outcome Measures: Including physical health, mental health, social functioning, quality of life, daily functioning, and health care resource utilizations. Feasibility analysis is applied to assess the possibility for large scale disseminations of the proposed project.;   The results of the proposed study will help shaping the geriatric healthcare policy toward the goal of "active aging" in Taiwanese community-dwelling elders.
10 Recruiting Gaining Optimal Osteoporosis Assessments in Long-Term Care (GOAL)
Condition: Osteoporosis
Intervention: Other: Knowledge Translation Education Sessions
Outcome Measures: Difference in the percentage of residents appropriately prescribed an Osteoporosis medication before and after the intervention.;   Difference in the percentage of residents prescribed Vitamin D (equivalent to ≥800 IU/day) before and after the intervention.
11 Not yet recruiting Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday
Condition: Osteoporosis
Intervention: Other: Questionnaires about compliance and persistence with bisphosphonates treatment
Outcome Measure: Compliance and persistence to Osteoporosis drug therapy
12 Recruiting Weekly vs Daily Teriparatide Therapy in Severe Postmenopausal Osteoporosis
Condition: Osteoporosis
Intervention: Drug: Teriparatide
Outcome Measures: BMD at Hip and lumber spine;   Reduction in fracture risk
13 Recruiting Improved Screening for Osteoporosis
Condition: Osteoporosis
Outcome Measure: Number of patients screened at risk for Osteoporosis
14 Unknown  Vitamin K as Additive Treatment in Osteoporosis
Condition: Post-Menopausal Osteoporosis
Interventions: Drug: Phylloquinone;   Drug: Menaquinone (MK4);   Drug: placebo
Outcome Measures: Primary outcome measures- Changes in BMD at the Lumber spine, hip, fore-arm at 18 months.;   Secondary outcome measure- Bone Turnover as assessed by the biochemical markers (serum CTX, P1NP, BALP, carboxylated and undercarboxylated osteocalcin (OC), OPG). These markers will be measured at the same time point during each clinic visit.
15 Not yet recruiting Growth Hormone for Osteoporosis Pseudoglioma Syndrome
Condition: Osteoporosis Pseudoglioma Syndrome
Intervention: Biological: Human recombinant growth hormone
Outcome Measures: Bone quality by pQCT;   Body fat percent
16 Recruiting Effects of Teriparatide (PTH) on Bone in Men and Women With Osteoporosis
Condition: Osteoporosis
Intervention: Drug: Teriparatide
Outcome Measure: Change in cortical thickness at the radius and tibia as measured by high-resolution quantitative computer tomography (HR-pQCT)
17 Not yet recruiting C-STOP Fracture Trial
Condition: Osteoporosis
Interventions: Other: case management;   Other: Multifaceted quality improvement intervention
Outcome Measure: Proportion of untreated patients newly starting prescription Osteoporosis treatment with a bisphosphonate after their fracture
18 Unknown  Prevalence of Osteoporosis in Patients Who Uses Inhaled Steroids
Condition: Osteoporosis
Intervention: Device: Dual energy X-ray absorptiometry
Outcome Measure: Diagnosis of Osteoporosis
19 Not yet recruiting Longitudinal Study of Primary Osteoporosis in Shanghai Postmenopausal Women
Condition: Primary Osteoporosis
Outcome Measures: Bone Mineral Density;   SF-36;   international Osteoporosis foundation ONE-MINUTE Osteoporosis RISK TEST;   Markers of bone metabolism test;   EQ-5D;   Hepatic-renal function test;   thyroid stimulating hormone level test
20 Recruiting Phase 2a Study on Intravenous Infusion of Autologous Osteoblastic Cells in Severe Osteoporosis
Condition: Severe Osteoporosis
Intervention: Drug: PREOB® Intravenous Infusion
Outcome Measures: Cell biodistribution after intravenous infusion as assessed by SPECT/CT scan;   Potential occurrence of any AE or SAE, related to the product, using patient open non-directive questionnaire, physical examination and laboratory measurements;   Pain measured by the Visual Analogue Scale;   Well-being score using SF-36 questionnaire;   Occurrence of new vertebral fractures as assessed by X-ray;   Bone mineral density evolution as assessed by Dual-energy X-ray absorptiometry (DEXA);   Measurement of bone formation and resorption markers

These studies may lead to new treatments and are adding insight into Osteoporosis etiology and treatment.

A major focus of Osteoporosis research is the development of new drugs and other treatment options. Studies seek to identify new drugs to treat various related disorders and to find safer, more effective doses for medications already being used. Other research is aimed at identifying receptors or drug targets.

Discuss Osteoporosis